Selexis
Selexis SA 公司是一家總部位于瑞士日內瓦的全球性生命科學公司。公司主要從事生命科學領域創新技術的研究工作;同時為新藥研發、細胞株開發、治療性蛋白的大規模產業化生產提供世界一流的專家服務工作。公司獨有的SUREtechnology平臺是一種新型基于DNA-based元素技術的蛋白表平臺,該新型技術能夠控制所有撲入動物細胞中染色質的動態組裝過程,從而促使哺乳動物細胞能夠穩定、高表達重組蛋白。從新藥的創新研發到后期臨床試驗,Selexis SA公司研究開發的細胞株已經被廣泛運用于生命科學研究領域。
Headquartered in Geneva, Switzerland, Selexis SA is a global life science company with innovative technologies and world-class expert services for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins. The Company’s SUREtechnology Platform? is based on Selexis Genetic Elements? — novel DNA-based elements that control the dynamic organization of chromatin within all mammalian cells and allow for higher and more stable expression of recombinant proteins. Selexis has generated cell lines being used in a variety of programs from drug discovery to late-stage clinical trials.